Thread: DDC announces success in treating Hepatitis C

BANGKOK, 8th May 2018 (NNT) – The Department of Disease Control (DDC) has announced the success of research into a new Hepatitis C remedy based on Sofosbuvir-Ledipasvir, which has proven to be effective in 97-100 percent of cases treated.

DDC Director-General Dr. Suwannachai Wattanayingcharoenchai and head of clinical research into HIV and Hepatitis C in the Drugs for Neglected Diseases Initiative (DNDi), Dr. Isabelle Andrieux-Meyer announced success in finding a treatment for the Hepatitis C virus, a major cause of chronic liver disease and liver cancer.

DNDi worked with the health ministries of Thailand and Malaysia between 2016 and 2017 to conduct the second and third phases of clinical tests of the treatment at 10 hospitals. The test focused on the effectiveness of combining Sofosbuvir and Ledipasvir and provided the drugs to patients at different stages of liver disease resulting from Hepatitis C. Test results showed a 97 percent success rate, even among those suffering from chronic liver disease.

Up to 96 percent of those with liver disease from Hepatitis C saw recovery while 97 percent of those with the disease due to the HIV virus also saw the ailment reversed.

Researchers noted the drug combination is not highly priced and that research will continue to expand its success to more strains of Hepatitis.


http://thainews.prd.go.th/website_en...C6105080010016

This is not new research Sofosbuvir in combination with one antiviral drug has been common treatment outside Thailand since 3-4 years back.
Sofosbuvir + Ledipasvir can cure 2 strains of HVC while Sofosbuvir + Velpatasvir can cure all 6 strains (genotypes).

Originally Posted by misskit

Researchers noted the drug combination is not highly priced and that research will continue to expand its success to more strains of Hepatitis.

That research is already done, sorry Thailand. Maybe you can become the hub of HVC treatment..